Konopka, Adam R
- University of Wisconsin-Madison · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,887
- Program Leader
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$2M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#3,887
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Konopka, Adam R as a PI. Multi-PI records show the full award amount for context.
- 5U01AG076941-02U01Contact PIClinical evaluation of mTORC1 inhibition for geroprotection.University of Wisconsin-Madison · Internal Medicine (NIH department code)$1.4Maward amount
- 1U01AG081482-01U01Contact PISafer mTOR inhibition for human geroprotectionUniversity of Wisconsin-Madison · Internal Medicine (NIH department code)$618.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Konopka, Adam R as a PI.
FY2023 award administered by University of Wisconsin-Madison (WI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardUniversity of Wisconsin-Madison
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #5629
- 2022Program/Center Grant Leader
- 2023$2M Cumulative Funding
- 2023Entered Top 25% NationallyRanked #3887